CDER releases annual ‘Accelerating Rare Disease Cures (ARC) Program’ report for 2024
The FDA’s Center For Drug Evaluation and Research (CDER) [...]
Why TMC is more than just a CRO
What is a clinical research organisation? By definition, a [...]
The role of pharmacovigilance in oncology drug trials
Some of our experts recently penned a thought-provoking article [...]
New Board members welcomed to TMC
Last week marked TMC's first Board meeting since our [...]
The FDA’s Project Optimus Initiative ~ expediting life-saving drugs to market without compromising on safety!
The Food and Drug Administration's (FDA) Project Optimus initiative, [...]
TMC welcomes Joe Lopez as Chief Financial Officer (CFO) to enhance corporate C-level team
Hampshire, UK — 03 June 2024 TMC Pharma Services Ltd., [...]
TMC welcomes Simon Estcourt as new Chief Executive Officer (CEO) to spearhead next phase of development
Hampshire, UK — 7 May 2024 TMC Pharma [...]
